Get the Stockscreener App
2.06
0.98%
0.02
Biocardia Inc stock is traded at $2.06, with a volume of 27,617.
It is up +0.98% in the last 24 hours and up +13.81% over the past month.
BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).
See More
Previous Close:
$2.04
Open:
$2.02
24h Volume:
27,617
Relative Volume:
0.10
Market Cap:
$11.95M
Revenue:
$468.00K
Net Income/Loss:
$-10.34M
P/E Ratio:
-0.2922
EPS:
-7.05
Net Cash Flow:
$-8.94M
1W Performance:
+4.20%
1M Performance:
+13.81%
6M Performance:
-18.90%
1Y Performance:
-17.60%
1-Day Range:
$1.9901
$2.09
1-Week Range:
$1.9254
$2.09
52-Week Range:
$1.625
$3.2584
Biocardia Inc Stock (BCDA) Company Profile
Name
Biocardia Inc
Sector
Industry
Phone
650-226-0123
Address
320 SOQUEL WAY, SUNNYVALE, CA
Compare BCDA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| 0.41 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
1.78 | 1.86B | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.48 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
2.37 | 103.78M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.3441 | 797.28M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DAVEW
Dave Inc
|
1.15 | 0 | 0 | 0 | 0 | 0.00 |
Biocardia Inc Stock (BCDA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-16-21 | Downgrade | Dawson James | Buy → Neutral |
Biocardia Inc Stock (BCDA) Latest News
Will a bounce in BioCardia Inc. offer an exit2025 Winners & Losers & Growth Focused Stock Pick Reports - Newser
What indicators show strength in BioCardia Inc.Trade Analysis Report & Weekly High Return Stock Forecasts - Newser
Is BioCardia Inc. building a consolidation baseJuly 2025 Opening Moves & Advanced Technical Signal Analysis - Newser
How high can BioCardia Inc. stock goQuarterly Portfolio Report & Accurate Buy Signal Alerts - Newser
BioCardia Inc.’s volatility index tracking explainedJuly 2025 Opening Moves & Scalable Portfolio Growth Ideas - Newser
Should you wait for a breakout in BioCardia Inc.2025 Technical Overview & Free Risk Controlled Daily Trade Plans - Newser
What makes BioCardia Inc. stock price move sharply2025 Dividend Review & Daily Chart Pattern Signal Reports - Newser
Automated trading signals detected on BioCardia Inc.2025 Geopolitical Influence & Long Hold Capital Preservation Plans - Newser
Can BioCardia Inc. recover in the next quarter2025 Pullback Review & Pattern Based Trade Signal System - Newser
BioCardia CEO Peter Altman to Present at H.C. Wainwright Annual Global Investment Conference in New York City - AInvest
Cardiovascular Cell Therapy Updates: BioCardia CEO to Present Three Clinical Programs at NYC Conference - Stock Titan
RSI Reset May Fuel Rebound in BioCardia Inc.2025 Top Gainers & Daily Oversold Bounce Ideas - Newser
Is BioCardia Inc. part of any major index2025 Pullback Review & Weekly Sector Rotation Insights - خودرو بانک
Full technical analysis of BioCardia Inc. stock2025 Historical Comparison & Advanced Swing Trade Entry Plans - Newser
Tools to assess BioCardia Inc.’s risk profileJuly 2025 Market Mood & Risk Controlled Daily Trade Plans - Newser
Detecting support and resistance levels for BioCardia Inc.Breakout Watch & Comprehensive Market Scan Reports - Newser
What moving averages say about BioCardia Inc.Quarterly Investment Review & High Conviction Investment Ideas - Newser
Is BioCardia Inc. stock entering bullish territoryBull Run & Verified Stock Trade Ideas - Newser
Analyzing recovery setups for BioCardia Inc. investorsPortfolio Update Summary & Low Drawdown Trading Strategies - Newser
Is it too late to sell BioCardia Inc.2025 Price Action Summary & Fast Entry and Exit Trade Plans - Newser
Is BioCardia Inc. a potential multi baggerWeekly Market Outlook & Daily Profit Maximizing Tips - خودرو بانک
BioCardia Inc. stock trendline breakdownSwing Trade & Safe Entry Point Alerts - Newser
Risk vs reward if holding onto BioCardia Inc.July 2025 Snapshot & Community Verified Trade Alerts - Newser
What the charts say about BioCardia Inc. todayPortfolio Return Report & Free Reliable Trade Execution Plans - Newser
Can BioCardia Inc. outperform in the next rally2025 Support & Resistance & Entry Point Strategy Guides - خودرو بانک
Tick level data insight on BioCardia Inc. volatilityEarnings Beat & Precise Buy Zone Identification - Newser
Breakout Watch: Is BioCardia Inc. a potential multi baggerJuly 2025 Update & Capital Protection Trade Alerts - خودرو بانک
BioCardia, Inc. (NASDAQ:BCDA) Q2 2025 Earnings Call Transcript - MSN
Relative strength of BioCardia Inc. in sector analysisPortfolio Risk Summary & Technical Pattern Based Buy Signals - Newser
Institution Moves: Is BioCardia Inc. in a long term uptrend2025 Valuation Update & Detailed Earnings Play Alerts - خودرو بانک
Can BioCardia Inc. Overcome Bearish Sentiment2025 Fundamental Recap & High Return Trade Opportunity Guides - beatles.ru
BioCardia’s Q2 Earnings Call Highlights Cautious Optimism Amid Regulatory Progress and Partnership Discussions - AInvest
BioCardia Inc. Stock Poised for Technical Comeback2025 Winners & Losers & Proven Capital Preservation Tips - beatles.ru
Tools to monitor BioCardia Inc. recovery probability2025 Volatility Report & AI Powered Trade Plan Recommendations - Newser
Forecasting BioCardia Inc. price range with options dataPortfolio Risk Summary & Low Drawdown Momentum Trade Ideas - Newser
Sentiment Tools Show Shift in Trader Mood on BioCardia Inc.July 2025 Action & AI Driven Price Forecasts - beatles.ru
What candlestick patterns are forming on BioCardia Inc.2025 Analyst Calls & Consistent Growth Equity Picks - Newser
How to escape a deep drawdown in BioCardia Inc.Wall Street Watch & Risk Adjusted Buy/Sell Alerts - Newser
Real time social sentiment graph for BioCardia Inc.Portfolio Gains Report & Consistent Income Trade Ideas - Newser
Biocardia Inc Stock (BCDA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Biocardia Inc Stock (BCDA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Altman Peter | President and CEO |
Aug 13 '25 |
Buy |
1.83 |
100 |
183 |
168,062 |
| Altman Peter | President and CEO |
Aug 12 '25 |
Buy |
1.75 |
400 |
700 |
167,962 |
| Altman Peter | President and CEO |
Aug 11 '25 |
Buy |
1.76 |
1,700 |
2,989 |
167,562 |
| McClung David | Chief Financial Officer |
Jun 30 '25 |
Buy |
2.08 |
4,819 |
9,999 |
47,950 |
| Altman Peter | President and CEO |
Jun 30 '25 |
Buy |
2.08 |
24,096 |
49,999 |
165,862 |
| STERTZER SIMON H | Director |
Jun 30 '25 |
Buy |
2.08 |
72,289 |
150,000 |
192,654 |
| Blank Andrew Scott | Director |
Jun 30 '25 |
Buy |
2.08 |
72,289 |
150,000 |
346,023 |
| Altman Peter | President and CEO |
May 30 '25 |
Buy |
2.21 |
100 |
221 |
141,766 |
| Altman Peter | President and CEO |
May 20 '25 |
Buy |
2.08 |
1,600 |
3,328 |
140,966 |
| Altman Peter | President and CEO |
May 22 '25 |
Buy |
1.89 |
700 |
1,323 |
141,666 |
1.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):